Krystal Biotech (KRYS) PT Raised to $395 at Evercore ISI
Tweet
Share
E-mailGet Alerts KRYS Hot Sheet
Price: $332.27 +1.20%
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Evercore ISI analyst Josh Schimmer raised the price target on Krystal Biotech (NASDAQ: KRYS) to $395.00 (from $300.00) while maintaining a Outperform rating.
You May Also Be Interested In
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
- Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
